Technology platform licensing

Licensing opportunities available

iCRT-deter offers a platform solution for the controlled release of potent and addictive compounds, including opioids. With abuse deterrent properties, and tailored release of active ingredients, iCRT-deter can help protect the patient and the product.

Partnering with Lucideon will offer:

• Formulation consultancy and development trials.
• Access to licensing rights.
• Product IP extension.

Through decades of partnership and collaboration we’ve learned that nothing accelerates R&D better than working together, and Lucideon adds value through partnership in more ways than one.

Partnering – innovation through collaboration:

• Exploit novel technology platforms.
• Focus your R&D.
• Accelerate your time to market.
• Boost your organization’s innovation.